Clinical Trials Directory

Trials / Unknown

UnknownNCT05506306

Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Henri Mondor University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Background and aim: Sustained bed rest impairs many bodily functions. Verticalization restores gravitational challenge and the use of several organs. The Atalante™ exoskeleton (Wandercraft) is the only self-balanced exoskeleton, which allows walking without canes. We assessed multi-tissular effects of mobile reverticalization using Atalante™ in neurological bed- or wheelchair-bound patients. Methods: Observational cohort study. Inclusion criteria: bed- or wheelchair-bound for \>2 weeks and \<1 hour per day of stance, due to a central neurological disorder. Sessions with exoskeleton were 3/week, integrated in routine care. Data collected at baseline and after eight weeks (W8) included: cardiovascular (echocardiography, EKG, blood pressure lying and standing), pulmonary (spirometry), bone (densitometry, biochemical markers), bowels (daily stool frequency, Bristol Stool Scale), urinary (urinary flow, postmictional residual volume, urinary symptom profile questionnaire, USP), cognitive (trail making test, TMT-B), anxiety and depression (HAD), and quality of life (SF12). Results will be presented at the end of the study.

Conditions

Interventions

TypeNameDescription
OTHERAssessmentClinical, biological and imagery before and after 6 weeks of using AtalanteTM exoskeleton

Timeline

Start date
2022-09-01
Primary completion
2023-09-01
Completion
2024-09-01
First posted
2022-08-18
Last updated
2022-08-18

Source: ClinicalTrials.gov record NCT05506306. Inclusion in this directory is not an endorsement.